Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
- Author
- DORMAN, Susan E1 ; GOLDBERG, Stefan2 ; NARITA, Masahiro7 ; NAHID, Payam8 ; RAY, Susan9 ; BATES, Edward10 ; HAILE, Betial11 ; NUERMBERGER, Eric L1 ; VERNON, Andrew2 ; SCHLUGER, Neil W12 ; STOUT, Jason E3 ; MUZANY, Grace4 ; JOHNSON, John L4 5 ; WEINER, Marc6 ; BOZEMAN, Lorna2 ; HEILIG, Charles M2 ; FENG, Pei-Jean2 ; MORO, Ruth2
[1] Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
[2] Centers for Disease Control and Prevention, Atlanta, Georgia, United States
[3] Duke University School of Medicine, Durham, North Carolina, United States
[4] Uganda-Case Western Reserve University Research Collaboration, Kampala, Uganda
[5] Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
[6] University of Texas Health Science Center at San Antonio and the South Texas VAMC, San Antonio, United States
[7] University of Washington, Seattle, United States
[8] University of California, San Francisco, United States
[9] Emory University School of Medicine, Atlanta, Georgia, United States
[10] University of North Texas, Denton, United States
[11] Westat, Inc., Rockville, Maryland, United States
[12] Columbia University Medical Center, New York, New York, United States
Tuberculosis Trials Consortium - Source
The Journal of infectious diseases. 2012, Vol 206, Num 7, pp 1030-1040, 11 p ; ref : 38 ref
- CODEN
- JIDIAQ
- ISSN
- 0022-1899
- Scientific domain
- Immunology, immunopathology, allergology; Microbiology, infectious diseases; Tropical medicine
- Publisher
- Oxford University Press, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antibactérien Antibiotique Antituberculeux Rifampicine Rifapentine Traitement Tuberculose pulmonaire Bactériose Infection Inhibiteur synthèse protéique Mycobactériose Pathologie de l'appareil respiratoire Pathologie des poumons
- Keyword (en)
- Antibacterial agent Antibiotic Antituberculous agent Rifampicin Rifapentine Treatment Pulmonary tuberculosis Bacteriosis Infection Protein synthesis inhibitor Mycobacterial infection Respiratory disease Lung disease
- Keyword (es)
- Antibacteriano Antibiótico Antituberculoso Rifampicina Rifapentina Tratamiento Tuberculosis pulmonar Bacteriosis Infección Inhibidor síntesis proteica Micobacteriosis Aparato respiratorio patología Pulmón patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002A Fundamental and applied biological sciences. Psychology / 002A05 Microbiology
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05B Bacterial diseases / 002B05B02 Human bacterial diseases / 002B05B02E Bacterial diseases of the respiratory system
- Discipline
- Infectious pathology Microbiology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 26399852
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1093/infdis/jis461 
https://dx.doi.org/10.1093/infdis/jis461
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"206\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1030\";s:8:\"\u0000*\u0000epage\";s:4:\"1040\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DORMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GOLDBERG, Stefan\";i:1;s:16:\"NARITA, Masahiro\";i:2;s:12:\"NAHID, Payam\";i:3;s:10:\"RAY, Susan\";i:4;s:13:\"BATES, Edward\";i:5;s:13:\"HAILE, Betial\";i:6;s:19:\"NUERMBERGER, Eric L\";i:7;s:14:\"VERNON, Andrew\";i:8;s:16:\"SCHLUGER, Neil W\";i:9;s:14:\"STOUT, Jason E\";i:10;s:13:\"MUZANY, Grace\";i:11;s:15:\"JOHNSON, John L\";i:12;s:12:\"WEINER, Marc\";i:13;s:14:\"BOZEMAN, Lorna\";i:14;s:17:\"HEILIG, Charles M\";i:15;s:14:\"FENG, Pei-Jean\";i:16;s:10:\"MORO, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"206\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1030\";s:8:\"\u0000*\u0000epage\";s:4:\"1040\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DORMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GOLDBERG, Stefan\";i:1;s:16:\"NARITA, Masahiro\";i:2;s:12:\"NAHID, Payam\";i:3;s:10:\"RAY, Susan\";i:4;s:13:\"BATES, Edward\";i:5;s:13:\"HAILE, Betial\";i:6;s:19:\"NUERMBERGER, Eric L\";i:7;s:14:\"VERNON, Andrew\";i:8;s:16:\"SCHLUGER, Neil W\";i:9;s:14:\"STOUT, Jason E\";i:10;s:13:\"MUZANY, Grace\";i:11;s:15:\"JOHNSON, John L\";i:12;s:12:\"WEINER, Marc\";i:13;s:14:\"BOZEMAN, Lorna\";i:14;s:17:\"HEILIG, Charles M\";i:15;s:14:\"FENG, Pei-Jean\";i:16;s:10:\"MORO, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"206\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1030\";s:8:\"\u0000*\u0000epage\";s:4:\"1040\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DORMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GOLDBERG, Stefan\";i:1;s:16:\"NARITA, Masahiro\";i:2;s:12:\"NAHID, Payam\";i:3;s:10:\"RAY, Susan\";i:4;s:13:\"BATES, Edward\";i:5;s:13:\"HAILE, Betial\";i:6;s:19:\"NUERMBERGER, Eric L\";i:7;s:14:\"VERNON, Andrew\";i:8;s:16:\"SCHLUGER, Neil W\";i:9;s:14:\"STOUT, Jason E\";i:10;s:13:\"MUZANY, Grace\";i:11;s:15:\"JOHNSON, John L\";i:12;s:12:\"WEINER, Marc\";i:13;s:14:\"BOZEMAN, Lorna\";i:14;s:17:\"HEILIG, Charles M\";i:15;s:14:\"FENG, Pei-Jean\";i:16;s:10:\"MORO, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"206\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1030\";s:8:\"\u0000*\u0000epage\";s:4:\"1040\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DORMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GOLDBERG, Stefan\";i:1;s:16:\"NARITA, Masahiro\";i:2;s:12:\"NAHID, Payam\";i:3;s:10:\"RAY, Susan\";i:4;s:13:\"BATES, Edward\";i:5;s:13:\"HAILE, Betial\";i:6;s:19:\"NUERMBERGER, Eric L\";i:7;s:14:\"VERNON, Andrew\";i:8;s:16:\"SCHLUGER, Neil W\";i:9;s:14:\"STOUT, Jason E\";i:10;s:13:\"MUZANY, Grace\";i:11;s:15:\"JOHNSON, John L\";i:12;s:12:\"WEINER, Marc\";i:13;s:14:\"BOZEMAN, Lorna\";i:14;s:17:\"HEILIG, Charles M\";i:15;s:14:\"FENG, Pei-Jean\";i:16;s:10:\"MORO, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1093\/infdis\/jis461\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:9:\"\u0000*\u0000jtitle\";s:34:\"The Journal of infectious diseases\";s:9:\"\u0000*\u0000stitle\";s:14:\"J. infect. dis\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:3:\"206\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:4:\"1030\";s:8:\"\u0000*\u0000epage\";s:4:\"1040\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0022-1899\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"DORMAN\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Susan E\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:16:\"GOLDBERG, Stefan\";i:1;s:16:\"NARITA, Masahiro\";i:2;s:12:\"NAHID, Payam\";i:3;s:10:\"RAY, Susan\";i:4;s:13:\"BATES, Edward\";i:5;s:13:\"HAILE, Betial\";i:6;s:19:\"NUERMBERGER, Eric L\";i:7;s:14:\"VERNON, Andrew\";i:8;s:16:\"SCHLUGER, Neil W\";i:9;s:14:\"STOUT, Jason E\";i:10;s:13:\"MUZANY, Grace\";i:11;s:15:\"JOHNSON, John L\";i:12;s:12:\"WEINER, Marc\";i:13;s:14:\"BOZEMAN, Lorna\";i:14;s:17:\"HEILIG, Charles M\";i:15;s:14:\"FENG, Pei-Jean\";i:16;s:10:\"MORO, Ruth\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JIDIAQ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:147:\"Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:23:\"Oxford University Press\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
